Loading…
Korean K-beauty skincare brand known for white-truffle serums/ampoules, sold direct-to-consumer and exported, notably to Japan.
Korean K-beauty skincare brand known for white-truffle serums/ampoules, sold direct-to-consumer and exported, notably to Japan.
Moat: narrow (brand). Fast-growing niche K-beauty brand riding social-media-driven demand, though trend-dependent.
Headquarters: South Korea · Employees: 203
Size d'Alba Global (483650.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $1.32B, the 192nd largest of 495 South Korea companies the cockpit tracks. Shares closed at ₩142,700 on 6 Nov 2026.
Performance Over six months the shares fell 36.9%, against -1.5% for the median peer and -24.5% for the South Korea market (cap-weighted) — 3rd lowest of 21 in its peer set.
Growth Revenue grew 55.4% over the last twelve months (peer median +8.0%); the operating margin is 21.1% (peer median 9.2%).
Valuation It trades at 13.6× forward earnings against a peer median of 20.3× (6th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about -2% a year for seven years (Req g). Recent delivered growth is +53%, so the hurdle is -55 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 174.4 points above its cost of capital (7.5% WACC).
Next results Next results expected around 12 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩639B | ₩520B | ₩309B | ₩201B | ₩145B |
| Revenue growth | — | +68% | +54% | +38% | — |
| Gross profit | ₩486B | ₩393B | ₩234B | ₩146B | n/a |
| EBITDA | ₩136B | ₩103B | ₩60.6B | ₩32.9B | n/a |
| Net income | ₩109B | ₩79.1B | ₩15.4B | ₩13.6B | ₩891M |
| Free cash flow | ₩95.2B | ₩68.2B | ₩15.0B | ₩24.2B | n/a |
| Capital expenditure | ₩1.37B | ₩380M | ₩1.14B | ₩79.0M | n/a |
| Total debt | ₩4.33B | ₩2.94B | ₩2.82B | ₩6.38B | ₩1.28B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 483650.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -21.9% | +1.6% | 4th lowest of 21 |
| 6-month return | -36.9% | -1.5% | 3rd lowest of 21 |
| Distance from 52-week high | -49.6% | -31.5% | 2nd lowest of 21 |
| Revenue growth (TTM) | +55.4% | +8.0% | 2nd highest of 21 |
| Operating margin | 21.1% | 9.2% | 2nd highest of 21 |
| Forward P/E | 13.6× | 20.3× | 6th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -2.2% | 4.3% | 5th least demanding of 18 |
| Growth delivered (Del g) | +53.0% | +6.1% | highest of 18 |
| Hurdle (Req g minus delivered) | -55.2 pp | -6.6 pp | least demanding of 18 |
| ROIC minus cost of capital | +174.4 pp | +5.2 pp | highest of 21 |
| EV / EBITDA | 11.7× | 10.6× | 5th most expensive of 11 |
| Net debt / EBITDA | -1.4× | -0.8× | 6th least indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| d'Alba Global 483650.KS | South Korea | $1.32B | -37% | +55% | 21% | 13.6× | -2.2% | +53.0% |
| Edgewell Personal Care EPC | United States | $1.29B | +32% | -7% | 6% | 12.4× | 4.1% | +2.7% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.22B | -52% | +23% | 8% | 15.0× | -5.9% | +21.2% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.45B | -4% | -6% | 2% | 37.0× | n/a | n/a |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% | +22.8% |
| Intercos ICOS.MI | Italy | $1.50B | +16% | -5% | 9% | 19.5× | 4.5% | +11.5% |
| AMOREPACIFIC 002790.KS | South Korea | $1.55B | -3% | +9% | 9% | 8.4× | -17.9% | -1.3% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.58B | -30% | +28% | 20% | 22.5× | 8.7% | +3.6% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.06B | 0% | +74% | 18% | 12.1× | 11.5% | +49.0% |
| Energizer ENR | United States | $1.63B | +26% | +2% | 16% | 7.2× | -5.2% | +1.5% |
| Pigeon 7956.T | Japan | $1.66B | +30% | +7% | 13% | 26.3× | -1.3% | +1.9% |
| SYoung 300740.SZ | China | $1.00B | -37% | +14% | 3% | 39.6× | 18.1% | +6.1% |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |
| Noevir 4928.T | Japan | $977M | +3% | +1% | 16% | 19.4× | -4.8% | +4.5% |
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $961M | +47% | +54% | 7% | 54.0× | n/a | n/a |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $944M | +15% | +10% | 11% | 28.9× | 4.3% | +10.8% |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| Runben Biotechnology 603193.SS | China | $940M | -33% | +13% | 21% | 18.9× | 1.7% | +28.4% |
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |